RAC 1.20% $1.68 race oncology ltd

Ann: Race Leadership Changes, page-311

  1. 818 Posts.
    lightbulb Created with Sketch. 122
    Has zantrene in the past 2yrs proven to be ineffective in any of the trials to date? Has zantrene underperformed in any trials to date?

    The answer is obviously no, so Zantrene hasnt let me down yet and has grown more and more valuable. At this stage the SP is seperate from the success of the drug. One day they will both hopefully be in sync. That is why i am here.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.68
Change
0.020(1.20%)
Mkt cap ! $286.2M
Open High Low Value Volume
$1.68 $1.68 $1.61 $177.8K 108.9K

Buyers (Bids)

No. Vol. Price($)
1 1100 $1.64
 

Sellers (Offers)

Price($) Vol. No.
$1.68 4999 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.